If your plan does cover Wegovy or Zepbound, the manufacturer savings cards (Novo Nordisk WegovyCare and Lillys Zepbound copay program) can bring monthly out-of-pocket as low as $25 for eligible commercially insured patients
With the development of new medications that target both GLP-1 and GIP receptors, the conversation around GLP-1 GIP dual agonist weight loss has intensified
GLP-1 receptor agonists: beyond their pancreatic effects
For now, it is still early for Wall Street to fully bake TrumpRx into detailed 2026 models
Because your clinician is a pro at preventative care, theyll help keep you ahead of potential medical problems
Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64